Efficacy of Olaparib ± Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Patients With Advanced TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Phase II DORA Study of Olaparib with or without Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Advanced Triple-Negative Breast Cancer
Clin. Cancer Res 2024 Jan 18;[EPub Ahead of Print], TJ Tan, S Sammons, YH Im, L She, K Mundy, R Bigelow, TA Traina, C Anders, J Yeong, E Renzulli, SB Kim, R DentFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.